Drugs / DEBRISOQUIN
last change Dec 2020 re-read 2 minutes ago

DEBRISOQUIN

Small molecule targets SLC6A2 via inhibition

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT00162383 Background Jul 1995 → Dec 2020 Hadassah Medical Organization Unknown No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as DEBRISOQUIN ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as DEBRISOQUIN SULFATE ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as Debrisoquin sulphate ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as Debrisoquina ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as Debrisoquine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00162383
Known as Debrisoquine sulfate ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as Declinax ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as NSC-139330 ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Known as RO 5-3307/1 ChEMBL registry synonym — accepted as the source's own label CHEMBL169901
Action Inhibit “Norepinephrine transporter inhibitor” CHEMBL169901
Modality Small molecule CHEMBL169901
Target SLC6A2 “Norepinephrine transporter inhibitor” CHEMBL169901